Comparison of the effects of acupressure points on patients undergoing chemotherapy

Not Applicable

Recruiting

• Conditions: chemotherapy.; Convalescence following chemotherapy; Z54.2

• Registration Number: IRCT20100829004655N12
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Patients 16 years and older
Patients with a definitive diagnosis of breast, colorectal, lung, prostate, and ovarian cancers by a specialist doctor
Patients who mention having nausea in their previous chemotherapy period
Patients who receive chemotherapy drugs by intravenous, port, or intravenous injection along with oral intake
Patients who have received at least one cycle of chemotherapy

Exclusion Criteria

Undergoing radiotherapy at the same time as chemotherapy
Using other complementary treatments at the same time
Having a known anxiety disorder
Having problems in the skin of acupressure points (for example, edema, lesions, or skin wounds) so that effective pressure cannot be applied
Having problems such as gastrointestinal diseases with nausea and vomiting, migraines, and tinnitus that are related to before the start of chemotherapy and interfere with nausea and vomiting of chemotherapy. This case will be reviewed based on the patient's statement or medical record
Patients who have a minimal risk of emesis chemotherapy regimen as determined by a specialist doctor.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ausea, whose score is measured by the Rhodes Nausea and Vomiting Questionnaire (statements 4, 5, and 7). Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Rhodes Nausea and Vomiting Questionnaire.;Vomiting, whose score is measured by the Rhodes Nausea and Vomiting Questionnaire (statements 1, 3, and 6). Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Rhodes Nausea and Vomiting Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Anxiety is measured by Spielberger's state-trait anxiety questionnaire. Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Spielberger's state-trait anxiety questionnaire.